Over-expression of KLF8 has been associated with a number of different cancer types including: ovarian carcinoma, renal cell carcinoma, hepatocellular carcinoma, breast cancer, gliomas, and gastric cancer [50–57]. Here, KLF8 is linked to central nervous system cancer.